India’s cancer focus must shift to early detection
This article argues that India's cancer strategy must shift from tertiary treatment to early detection to improve survival rates and reduce economic burdens on households. It highlights that late-stage diagnosis is a primary driver of both poor medical outcomes and catastrophic healthcare expenditure.
E very day, oncology clinics across India confront the same heartbreaking reality. More than 70% of patients present with advanced-stage cancer, when treatment is more complex, more expensive, and far less likely to achieve a cure. Over the past two decades, India has invested substantially in building world-class tertiary cancer centres and has expanded access to sophisticated surgery, radiation therapy, and systemic treatments. Yet these advances cannot deliver their full potential because most patients arrive too late.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in